Well, after a bit more research, I stumbled on a very good source of information about Sofpironium bromide and why Brickell Biotech (Fresh Tracks Therapeutics) decided to sell. Every BOT holder should try to read through this, has some good info -
https://www.sec.gov/Archives/edgar/data/819050/000081905022000016/bbi-20211231.htm
"Sofpironium bromide is not eligible for priority review or accelerated approval, based on the present criteria".
BOT - Anything but charting, page-3500
-
- There are more pages in this discussion • 6,196 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 782479 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |